ECSP034682A - Antagonistas de receptores de aminoacidos excitatorios - Google Patents

Antagonistas de receptores de aminoacidos excitatorios

Info

Publication number
ECSP034682A
ECSP034682A EC2003004682A ECSP034682A ECSP034682A EC SP034682 A ECSP034682 A EC SP034682A EC 2003004682 A EC2003004682 A EC 2003004682A EC SP034682 A ECSP034682 A EC SP034682A EC SP034682 A ECSP034682 A EC SP034682A
Authority
EC
Ecuador
Prior art keywords
ancigonists
receivers
amino acids
excitatory amino
salt
Prior art date
Application number
EC2003004682A
Other languages
English (en)
Inventor
Michael John Martinelli
Vien Van Khau
Michael Edward Letourneau
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ECSP034682A publication Critical patent/ECSP034682A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Una sal farmacéutica mente aceptable de un compuesto de fórmula: (gráfico) o un pro fármaco del mismo en la que la sal farmaceúticamente aceptable se selecciona del grupo constituido por la sal del ácido D-( -)-mandélico o la sal del ácido 1, 5-naftalenodisulfónico.
EC2003004682A 2001-01-05 2003-07-03 Antagonistas de receptores de aminoacidos excitatorios ECSP034682A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26001401P 2001-01-05 2001-01-05

Publications (1)

Publication Number Publication Date
ECSP034682A true ECSP034682A (es) 2003-08-29

Family

ID=22987455

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004682A ECSP034682A (es) 2001-01-05 2003-07-03 Antagonistas de receptores de aminoacidos excitatorios

Country Status (23)

Country Link
EP (1) EP1351955A1 (es)
JP (1) JP2004520335A (es)
KR (1) KR20030066797A (es)
CN (1) CN1484642A (es)
AR (1) AR035679A1 (es)
BR (1) BR0116672A (es)
CA (1) CA2431545A1 (es)
CZ (1) CZ20031856A3 (es)
DZ (1) DZ3460A1 (es)
EA (1) EA200300770A1 (es)
EC (1) ECSP034682A (es)
HR (1) HRP20030544A2 (es)
HU (1) HUP0302528A2 (es)
IL (1) IL156138A0 (es)
MX (1) MXPA03005981A (es)
NO (1) NO20032973D0 (es)
NZ (1) NZ525821A (es)
PE (1) PE20020792A1 (es)
PL (1) PL361934A1 (es)
SK (1) SK8242003A3 (es)
TW (1) TW591023B (es)
WO (1) WO2002053561A1 (es)
ZA (1) ZA200304311B (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
EP1053234A1 (en) * 1998-02-06 2000-11-22 Smithkline Beecham Plc Salts of paroxetine
GB9908175D0 (en) * 1999-04-09 1999-06-02 Lilly Co Eli Method of treating neurological disorders
DE60032905T2 (de) * 1999-07-06 2007-10-18 Eli Lilly And Co., Indianapolis Selektive iglur5 rezeptorantagonisten zur behandlung der migräne

Also Published As

Publication number Publication date
CZ20031856A3 (cs) 2003-09-17
HRP20030544A2 (en) 2004-08-31
NZ525821A (en) 2004-07-30
EP1351955A1 (en) 2003-10-15
WO2002053561A1 (en) 2002-07-11
TW591023B (en) 2004-06-11
CA2431545A1 (en) 2002-07-11
JP2004520335A (ja) 2004-07-08
EA200300770A1 (ru) 2003-10-30
ZA200304311B (en) 2004-09-02
HUP0302528A2 (hu) 2003-11-28
NO20032973L (no) 2003-06-27
PL361934A1 (en) 2004-10-18
KR20030066797A (ko) 2003-08-09
NO20032973D0 (no) 2003-06-27
MXPA03005981A (es) 2003-09-10
PE20020792A1 (es) 2002-09-06
BR0116672A (pt) 2003-09-23
IL156138A0 (en) 2003-12-23
DZ3460A1 (fr) 2002-07-11
SK8242003A3 (en) 2004-01-08
AR035679A1 (es) 2004-06-23
CN1484642A (zh) 2004-03-24

Similar Documents

Publication Publication Date Title
CO5271657A1 (es) Derivados de azaindol
HRP20020428B1 (en) Bicyclic amino acids as pharmaceutical agents
EA200300065A1 (ru) Окисленные сложные эфиры 4-йодфениламинобензгидроксамовых кислот
ECSP034603A (es) Combinaciones sinergicas que comprenden un inhibidor de renina para enfermedades cardiovasculares
BR9900443A (pt) Esteres de ácido aril acrìlico.
UY27273A1 (es) Solución oral de arilpiprazol
CY1107146T1 (el) Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad)
CO5720995A2 (es) Compuesto novedoso
AR051778A2 (es) Derivados del acido dimetilaminocrotonico y procesos para supreparacion
DE69507614D1 (de) 3-amino-2-oxo-piperidinessigsäurederivate, die eine argininnachahmende verbindung, mit enzyminhibitorischen wirkung enthalten
AR025307A1 (es) Compuesto de liberacion sostenida de un peptido, microparticulas, composicion farmaceutica y el uso de dicho compuesto para la fabricacion de un medicamento
CY1120408T1 (el) Βελτιωμενες φαρμακοτεχνικες μορφες
BR0002073A (pt) Processo para a preparação de um composto quiral
CO5280222A1 (es) Composicion farmaceutica que comprende pemetrexed
DE60027144D1 (de) Hydroxamsäure-derivate
MY133507A (en) New peroxy-carboxylic acid and aqueous compositions thereof
ES2190422T3 (es) Antagonistas selectivos de receptores de adenosina a2b.
AR021232A1 (es) Procedimiento de preparacion de metionina.
DK1341749T3 (da) Fremgangsmåde til fremstilling af gabapentin
DE69327890T2 (de) Verfahren zur Herstellung von 2-(un)substituierten 4-Alkylimidazolen
ES2422081T3 (es) Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
BR0212772A (pt) Processo para a preparação de repaglinida
EP1306367A4 (en) SULFONIC ACID DERIVATIVES OF HYDROXAMIC ACIDS AND THEIR USE AS MEDICAL PRODUCTS
ECSP034682A (es) Antagonistas de receptores de aminoacidos excitatorios
WO2002026732A1 (fr) Derive de benzodiazepine